The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of epirubicin combined with anlotinib followed by anlotinib in the first-line treatment of advanced unresectablesoft tissue sarcoma.
 
Yuhong Zhou
No Relationships to Disclose
 
Zhiming Wang
No Relationships to Disclose
 
Rongyuan Zhuang
No Relationships to Disclose
 
Xi Guo
No Relationships to Disclose
 
Chenlu Zhang
No Relationships to Disclose
 
Yang You
No Relationships to Disclose
 
Lisha Chen
No Relationships to Disclose
 
Wenshuai Liu
No Relationships to Disclose
 
Yong Zhang
No Relationships to Disclose
 
Weiqi Lu
No Relationships to Disclose